PubMed for id: 8649

Year	Number of Results
1994	1
1998	1
2001	2
2002	2
2003	1
2004	6
2005	3
2006	3
2007	2
2008	2
2009	2
2010	2
2011	7
2012	3
2013	4
2014	2
2015	4
2017	6
2018	1
2019	4
2020	6
2021	5
2022	7
2023	3
2024	0

1

LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma.

Gong Y, Lv Y, Xu F, Xiu Y, Lu Y, Liu Z, Deng L. Gong Y, et al. J Clin Lab Anal. 2022 Sep;36(9):e24648. doi: 10.1002/jcla.24648. Epub 2022 Aug 10. J Clin Lab Anal. 2022. PMID: 36082464 Free PMC article.

2

[Expression and Clinical Significance of Late Endosomal/Lysosomal Adaptor,Mitogen-activated Protein Kinase and Mammalian Target of Rapamycin Activator 3 in Bladder Carcinoma].

Deng LH, Xu FH, Zeng T, Xu XD, Chao HC. Deng LH, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019 Oct 30;41(5):601-608. doi: 10.3881/j.issn.1000-503X.10993. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019. PMID: 31699189 Chinese.

3

Role of MEK partner-1 in cancer stemness through MEK/ERK pathway in cancerous neural stem cells, expressing EGFRviii.

Kwon SJ, Kwon OS, Kim KT, Go YH, Yu SI, Lee BH, Miyoshi H, Oh E, Cho SJ, Cha HJ. Kwon SJ, et al. Mol Cancer. 2017 Aug 22;16(1):140. doi: 10.1186/s12943-017-0703-y. Mol Cancer. 2017. PMID: 28830458 Free PMC article.

4

Gastrin-induced proliferation involves MEK partner 1 (MP1).

Steigedal TS, Prestvik WS, Selvik LK, Fjeldbo CS, Bruland T, Lægreid A, Thommesen L. Steigedal TS, et al. In Vitro Cell Dev Biol Anim. 2013 Mar;49(3):162-9. doi: 10.1007/s11626-013-9588-2. Epub 2013 Feb 14. In Vitro Cell Dev Biol Anim. 2013. PMID: 23408059 Free PMC article.

5

MEK partner 1 (MP1): regulation of oligomerization in MAP kinase signaling.

Sharma C, Vomastek T, Tarcsafalvi A, Catling AD, Schaeffer HJ, Eblen ST, Weber MJ. Sharma C, et al. J Cell Biochem. 2005 Mar 1;94(4):708-19. doi: 10.1002/jcb.20344. J Cell Biochem. 2005. PMID: 15547943

6

Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction.

Teis D, Wunderlich W, Huber LA. Teis D, et al. Dev Cell. 2002 Dec;3(6):803-14. doi: 10.1016/s1534-5807(02)00364-7. Dev Cell. 2002. PMID: 12479806 Free article.

7

Circ_0075829 facilitates the progression of pancreatic carcinoma by sponging miR-1287-5p and activating LAMTOR3 signalling.

Zhang X, Xue C, Cui X, Zhou Z, Fu Y, Yin X, Wu S, Gong Y, Liu Y, Zhu C, Qin X. Zhang X, et al. J Cell Mol Med. 2020 Dec;24(24):14596-14607. doi: 10.1111/jcmm.16089. Epub 2020 Nov 13. J Cell Mol Med. 2020. PMID: 33184989 Free PMC article.

8

BCL2 induced by LAMTOR3/MAPK is a druggable target of chemoradioresistance in mesenchymal lung cancer.

Kwon OS, Hong SK, Kwon SJ, Go YH, Oh E, Cha HJ. Kwon OS, et al. Cancer Lett. 2017 Sep 10;403:48-58. doi: 10.1016/j.canlet.2017.05.019. Epub 2017 Jun 10. Cancer Lett. 2017. PMID: 28606806

9

A miR-29c binding site genetic variant in the 3'-untranslated region of LAMTOR3 gene is associated with gastric cancer risk.

Song P, Wang W, Tao G, Chu H, Wang M, Wu D, Tong N, Gong W, Zhou J, Zhang Z, Wang B, Zhu H, Zhao Q. Song P, et al. Biomed Pharmacother. 2015 Feb;69:70-5. doi: 10.1016/j.biopha.2014.11.008. Epub 2014 Nov 15. Biomed Pharmacother. 2015. PMID: 25661340

10

Polymorphisms in the gene regions of the adaptor complex LAMTOR2/LAMTOR3 and their association with breast cancer risk.

De Araujo ME, Erhart G, Buck K, Müller-Holzner E, Hubalek M, Fiegl H, Campa D, Canzian F, Eilber U, Chang-Claude J, Coassin S, Haun M, Kedenko L, Paulweber B, Reitsamer R, Himmel I, Flesch-Janys D, Lamina C, Kronenberg F, Huber LA, Kloss-Brandstätter A. De Araujo ME, et al. PLoS One. 2013;8(1):e53768. doi: 10.1371/journal.pone.0053768. Epub 2013 Jan 16. PLoS One. 2013. PMID: 23341997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

72 results

Results by year